ARCHIVES

New Approach To Replacing Immune Cells Shrinks Tumors

This article is from The Cancer Letter archive.

Vol. 25 No. 9 | September 27, 2002

Download PDF Visit The Full Archive

Related Articles

Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation

June 29, 2012

Obituary: Ronald Herberman, 72, UPCI Founding Director

July 3, 2013

In Brief: Rogers Indicates He May Let Training Grant Bill Die

March 29, 1974

ASCO Proposes Two IOM Workshops On Changing Clinical Trials Group System

September 17, 2010

DCCR Free Up $5 Million; New Policy Limits Core Support

November 5, 1976

NCCS Networker Volume 4 Issue 4, Fall 1990

September 13, 1990